Search - Université de Rennes Access content directly

Filter your results

27 Results
authFullName_s : Victor de Ledinghen
Image document

Early diagnosis of NAFLD-NASH transition using mid infrared spectroscopy.

Siouar Bensaid , Amar Kachenoura , Nathalie Costet , Victor de Ledinghen , Julien Vergniol et al.
Conference proceedings : .. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference, 2016, pp.3602-3605. ⟨10.1109/EMBC.2016.7591507⟩
Journal articles inserm-01476033v1

No evidence of hepatitis B virus reactivation among liver transplant recipients treated with interferon- free regimens for hepatitis C virus recurrence (ANRS CO23 CUPILT Cohort)

Lina Mouna , Emilie Rossignol , Mariagrazia Tateo , Jean-Charles Duclos-Vallee , Christophe Duvoux et al.
Hepatology, 2017, 66, pp.873A-874A
Journal articles hal-01769634v1

ABO blood group does not influence Child‐Pugh A cirrhosis outcome: An observational study from CIRRAL and ANRS CO12 CIRVIR cohorts

Isabelle Ollivier-Hourmand , Yohann Repesse , Pierre Nahon , Cendrine Chaffaut , Thông Dao et al.
Liver International, 2022, 42 (6), pp.1386-1400. ⟨10.1111/liv.15159⟩
Journal articles hal-03553907v1
Image document

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.

Christophe Hézode , Hélène Fontaine , Céline Dorival , Fabien Zoulim , Dominique Larrey et al.
Gastroenterology, 2014, 147 (1), pp.132-142.e4. ⟨10.1053/j.gastro.2014.03.051⟩
Journal articles inserm-01057763v1

EFFICACY AND SAFETY OF TREATMENT WITH BULEVIRTIDE IN CHRONIC HEPATITIS DELTA: PRELIMINARY RESULTS OF THE REAL LIFE ANRS HD EP01 BULEDELTA COHORT

Fabien Zoulim , Claire Fougerou , Roulot Marullo Dominique , Sophie Metivier , Victor de Ledinghen et al.
Hepatology, 2022, 76 (Supp 1), pp.S221-S223
Journal articles hal-03922586v1
Image document

Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis

Nathalie Ganne-Carrié , Cendrine Chaffaut , Valérie Bourcier , Isabelle Archambeaud , Jean-Marc Perarnau et al.
Journal of Hepatology, 2018, 69 (6), pp.1274-1283. ⟨10.1016/j.jhep.2018.07.022⟩
Journal articles hal-01880156v1
Image document

Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study

Victor de Ledinghen , Claire Laforest , Christophe Hezode , Stanislas Pol , Alain Renault et al.
Infectious Diseases in Clinical Practice, 2018, 66 (7), pp.1013-1018. ⟨10.1093/cid/cix916⟩
Journal articles hal-01743768v1
Image document

Extrahepatic cancers are the leading cause of death in patients achieving hepatitis B virus control or hepatitis C virus eradication

Manon Allaire , Pierre Nahon , Richard Layese , Valérie Bourcier , Carole Cagnot et al.
Hepatology, 2018, 68 (4), pp.1245-1259. ⟨10.1002/hep.30034⟩
Journal articles hal-02648452v1

Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs

Pierre Nahon , Richard Layese , Valérie Bourcier , Carole Cagnot , Patrick Marcellin et al.
Gastroenterology, 2018, 155 (5), pp.1436-1450.e6. ⟨10.1053/j.gastro.2018.07.015⟩
Journal articles hal-02648450v1

Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study.

Jean-Pierre Zarski , Nathalie Sturm , Jérôme Guechot , Adeline Paris , Elie-Serge Zafrani et al.
Journal of Hepatology, 2012, 56 (1), pp.55-62. ⟨10.1016/j.jhep.2011.05.024⟩
Journal articles istex hal-00866960v1
Image document

Direct-acting antiviral agent-based regimen for HCV recurrence after combined liver-kidney transplantation: Results from the ANRS CO23 CUPILT study

Sébastien Dharancy , Audrey Coilly , Claire Fougerou-Leurent , Christophe Duvoux , Nassim Kamar et al.
American Journal of Transplantation, 2017, 17 (11), pp.2869-2878. ⟨10.1111/ajt.14490⟩
Journal articles hal-01640061v1
Image document

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment a prospective cohort study

Fabrice Carrat , Hélène Fontaine , Céline Dorival , Mélanie Simony , Alpha Diallo et al.
The Lancet, 2019, 393 (10179), pp.1453-1464. ⟨10.1016/S0140-6736(18)32111-1⟩
Journal articles hal-02050395v1

Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence Prophylaxis makes the difference

Lina Mouna , Emilie Rossignol , Mariagrazia Tateo , Audrey Coilly , Jean-Charles Duclos-Vallee et al.
Journal of Hepatology, 2019, 70 (6), pp.1297-1300. ⟨10.1016/j.jhep.2019.02.019⟩
Journal articles hal-02120675v1

Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study

Charlotte Costentin , Richard Layese , Valérie Bourcier , Carole Cagnot , Patrick Marcellin et al.
Gastroenterology, 2018, 155 (2), pp.431-442.e10. ⟨10.1053/j.gastro.2018.04.027⟩
Journal articles hal-02648451v1

Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values results from the ANRS CO23 CUPILT cohort

Aurélie Barrail-Tran , Lauriane Goldwirt , Thibaut Gelé , Claire Laforest , Audrey Lavenu et al.
European Journal of Clinical Pharmacology, 2019, 75 (11), pp.1555-1563. ⟨10.1007/s00228-019-02725-x⟩
Journal articles hal-02280498v1

The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial

Christophe Bureau , Dominique Thabut , Caroline Jezequel , Isabelle Archambeaud , Louis D’alteroche et al.
Annals of Internal Medicine, 2021, 174 (5), pp.633-640. ⟨10.7326/M20-0202⟩
Journal articles hal-03229022v1

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS).

Marc Bourlière , Jean-Pierre Bronowicki , Victor de Ledinghen , Christophe Hézode , Fabien Zoulim et al.
The Lancet Infectious Diseases, 2015, 15 (4), pp.397-404. ⟨10.1016/S1473-3099(15)70050-2⟩
Journal articles hal-01134440v1
Image document

New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD

Jérôme Boursier , Maeva Guillaume , Vincent Leroy , Marie Irlès , Marine Roux et al.
Journal of Hepatology, 2019, 71 (2), pp.389-396. ⟨10.1016/j.jhep.2019.04.020⟩
Journal articles hal-02416110v1
Image document

Large-scale screening of lipase acid deficiency in at risk population

Abdellah Tebani , Bénédicte Sudrié-Arnaud , Hela Boudabous , Anais Brassier , Rodolphe Anty et al.
Clinica Chimica Acta, 2021, 519, pp.64-69. ⟨10.1016/j.cca.2021.04.005⟩
Journal articles hal-03223991v1

Real life study of bulevirtide in chronic hepatitis delta: preliminary results of the ANRS HD EP01 BuleDelta prospective cohort

Hélène Fontaine , Claire Fougerou-Leurent , Emmanuel Gordien , Caroline Scholtès , Sophie Métivier et al.
Journal of Hepatology, 2022, 77, pp.S72-S72
Journal articles hal-03770282v1
Image document

Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?

Audrey Coilly , Jérôme Dumortier , Danielle Botta-Fridlund , Marianne Latournerie , Vincent Leroy et al.
PLoS ONE, 2015, 10 (9), pp.e0138091. ⟨10.1371/journal.pone.0138091⟩
Journal articles hal-01326372v1

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890

Christophe Hézode , Hélène Fontaine , Céline Dorival , Dominique Larrey , Fabien Zoulim et al.
Journal of Hepatology, 2013, 59 (3), pp.434 - 441. ⟨10.1016/j.jhep.2013.04.035⟩
Journal articles hal-01708037v1

12 weeks of a Ribavirin-free Sofosbuvir and NS5A inhibitor regimen is enough to treat recurrence of hepatitis C after liver transplantation

Pauline Houssel-Debry , Audrey Coilly , Claire Fougerou-Leurent , Caroline Jezequel , Christophe Duvoux et al.
Hepatology, 2018, 68 (4), pp.1277-1287. ⟨10.1002/hep.29918⟩
Journal articles hal-01807755v1
Image document

Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?

Lucy Meunier , Mohamed Belkacemi , George Philippe Pageaux , Sylvie Radenne , Anaïs Vallet-Pichard et al.
Viruses, 2023, 15 (1), pp.137. ⟨10.3390/v15010137⟩
Journal articles hal-03980202v1

Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study

Charlotte Costentin , Richard Layese , Valérie Bourcier , Carole Cagnot , Patrick Marcellin et al.
Gastroenterology, 2018, 155 (2), pp.431-442.e10. ⟨10.1053/j.gastro.2018.04.027⟩
Journal articles hal-04075104v1
Image document

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

Georges‐philippe Pageaux , Clovis Lusivika Nzinga , Nathalie Ganne , Didier Samuel , Céline Dorival et al.
BMC Infectious Diseases, 2022, 22 (1), pp.94. ⟨10.1186/s12879-022-07076-0⟩
Journal articles hal-03555553v1

Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications

Pierre Nahon , Valérie Bourcier , Richard Layese , Etienne Audureau , Carole Cagnot et al.
Gastroenterology, 2017, 152 (1), pp.142-156.e2. ⟨10.1053/j.gastro.2016.09.009⟩
Journal articles hal-01447065v1